NCT02317575View on ClinicalTrials.gov

A Study of LY900014 Formulations in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

LY900014

Administered SC

BIOLOGICAL

Insulin Lispro

Administered SC

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02317575 - A Study of LY900014 Formulations in Healthy Participants | Biotech Hunter | Biotech Hunter